Stretching the mutant prevention concentration (MPC) beyond its limits

被引：52
|
作者：
Smith, HJ
Nichol, KA
Hoban, DJ
Zhanel, GG
机构：
[1] Hlth Sci Ctr, Dept Clin Microbiol, Winnipeg, MB R3A 1R9, Canada
[2] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada
[3] Hlth Sci Ctr, Dept Med, Winnipeg, MB R3A 1R9, Canada
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 06期
关键词：
mutant prevention concentration; resistance mechanisms;
D O I：
10.1093/jac/dkg255
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1323 / 1325
页数：3
相关论文
共 50 条
  • [31] The mutant prevention concentration (MPC) of gemifloxacin against clinical isolates of Streptococcus pneumoniae (SP) that were susceptible (PS), intermediate (PI) or resistant (PR) to penicillin
    Blondeau, JM
    Drlica, K
    Hansen, G
    Zhao, X
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 37 - 37
  • [32] Determination of minimal inhibitory concentration (MIC) and mutant prevention concentration (MPC) of ocular isolates of Pseudomonas aeruginosa(PA) and Haemophilus influenzae (HI) to 5 fluorquinolone (FQ) antimicrobial agents (AA).
    Metzler, K
    Hedlin, P
    Blondeau, JM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U555 - U555
  • [33] The Mutant Prevention Concentration strategy for minimizing the risk of antimicrobial resistance
    Blondeau, J. M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 : 67 - 67
  • [34] Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria
    Sindelar, G
    Zhao, XL
    Liew, A
    Dong, YZ
    Lu, T
    Zhou, JF
    Domagala, J
    Drlica, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3337 - 3343
  • [35] Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus
    Quinn, Brian
    Hussain, Syed
    Malik, Muhammad
    Drlica, Karl
    Zhao, Xilin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1380 - 1383
  • [36] Mutant prevention concentration:: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
    Rodríguez, JC
    Cebrián, L
    López, M
    Ruiz, M
    Jiménez, I
    Royo, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (03) : 441 - 444
  • [37] Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae
    Hansen, GT
    Metzler, K
    Drlica, K
    Blondeau, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 440 - 441
  • [38] Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis
    Jaganath, Devan
    Schaaf, H. Simon
    Donald, Peter R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 1848 - 1857
  • [39] New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach
    Blondeau, Joseph M.
    VETERINARY DERMATOLOGY, 2009, 20 (5-6) : 383 - 396
  • [40] Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates
    Bordallo-Cardona, Maria Angeles
    Marcos-Zambrano, Laura Judith
    Sanchez-Carrillo, Carlos
    de la Pedrosa, Elia Gomez G.
    Canton, Rafael
    Bouza, Emilio
    Escribano, Pilar
    Guinea, Jesus
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
12345